We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

How DNA ‘Proofreader’ Proteins Pick and Edit Their Reading Material

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 2 minutes

When a cell prepares to divide, the DNA splits first, the double helix “unzipping” into two separate backbones. New nucleotides – adenine, cytosine, guanine or thymine – are filled into the gaps on the other side of the backbone, pairing with their counterparts (adenine with thymine and cytosine with guanine) and replicating the DNA to make a copy for both the old and the new cells. The nucleotides are a correct match most of the time, but occasionally – about one time in a million – there is a mismatch.

Fortunately, our bodies have a system for detecting and repairing these mismatches – a pair of proteins known as MutS and MutL. MutS slides along the newly created side of the DNA strand after it’s replicated, proofreading it. When it finds a mismatch, it locks into place at the site of the error and recruits MutL to come and join it. MutL puts a nick in the newly synthesized DNA strand to mark it as defective and signals a different protein to gobble up the portion of the DNA containing the error. Then the nucleotide matching starts over, filling the gap again. The entire process reduces replication errors around a thousand fold, serving as our body’s best defense against genetic mutations and the problems that can arise from them, like cancer.

repair-848x271.jpg

“Every living thing uses this process for DNA replication and repair, and we know what the components are, but there are some key mechanisms that aren’t well understood,” says Keith Weninger, professor of physics at NC State and co-author of a paper describing the research. “For example, when the DNA is repaired, it only happens on the new portion of the DNA strand, and not the older template. And the proteins know which way to move along the strand in order to get rid of the defective portion. There’s communication happening here, but disagreement about how it works.”

Scientists know that a protein called PCNA plays an important role in this communication. PCNA sits at the site of a DNA split, and its physical orientation at that site indicates which part of a DNA strand is new. This is called a strand discrimination signal. Somehow, MutS and MutL interact with that signal, allowing MutL to nick the strand in the proper place and indicate need for repair. Scientists have three models for this communication: MutS and MutL combine to form a clamp that slides toward PCNA to interact with the signal, marking the area they slide along for deletion; or they make a fold in the DNA and “pull” the PCNA toward them to the same effect; or MutL somehow coats the defective area, signaling for repair that way.

Weninger, along with co-author Dorothy Erie from UNC-Chapel Hill, set out to determine the most likely method of communication. Using single molecule fluorescence methods, which allowed the researchers to watch one protein moving on one piece of DNA at a time, they determined that when MutS finds an error, it changes shape in a way that allows MutL to bind with it, holding it in place at the site of the mismatch. MutL then changes its shape to “grab” another MutL, and so on, coating the defective part of the strand and nicking the area that needs repair. In other words, Weninger, Erie and their colleagues found that the third model was the correct one.

“This system is essential to keeping the genome stable,” says Weninger. “We know all the players and the beginning and end of the process, but this work fills in one of the middle steps that was completely unknown and very different from what some have imagined.

“We also know that mutations in MutS and MutL are associated with very specific cancers,” he continues. “But if we’re going to figure out how defects lead to disease, we first must understand how these proteins normally do their job. This research is another step toward that understanding.”